Publikationen der AG Neuro-gliale Pharmakologie

Pub_links

• orcid.org

• researcher id

• researchgate

  ?

Selected publications

• Roman C, Vivi E, Di Benedetto B. Morphological Features of Astrocytes in Health and Neuropsychiatric Disorders. ?Adv Neurobiol. 2021;26:75-92. doi: 10.1007/978-3-030-77375-5_4. PMID: 34888831
• Malik VA, Zajicek F, Mittmann LA, Klaus J, Unterseer S, Rajkumar S, Pütz B, Deussing JM, Neumann ID, Rupprecht R, Di Benedetto B.?GDF15 promotes simultaneous astrocyte remodeling and tight junction strengthening at the blood-brain barrier.?J Neurosci Res. 2020 Jul;98(7):1433-1456. doi: 10.1002/jnr.24611. Epub 2020 Mar 13. PMID: 32170776
• Di Benedetto B. Focus on Mitogen-Activated Kinase Phosphatase-1: Looking for the Roots of Depression in the Anterior Cingulate Cortex. Biol Psychiatry 2017; 82(5):e33-e34.
• Di Benedetto B. Ephrins in astrocytes: synaptic erasers on stage. Oncotarget 2017;8(4):5676-5677.
• Tanasic S, Mattusch C, Wagner EM, Eder M, Rupprecht R, Rammes G, Di Benedetto B. Desipramine targets astrocytes to attenuate synaptic plasticity via modulation of the ephrinA3/EphA4 signalling. Neuropharmacology 2016; 105: 154-163.
• Di Benedetto B, Malik VA, Begum S, Jablonowski L, Gómez-González GB, Neumann ID, et al. Fluoxetine requires the endfeet protein aquaporin-4 to enhance plasticity of astrocyte processes. Frontiers in Cellular Neuroscience 2016; 10.
• Jakovcevski M, Akbarian S, Di Benedetto B. “Pharmacological modulation of astrocytes and the role of cell type-specific histone modifications for the treatment of mood disorders.”. Curr Opin Pharmacol. 2015 Oct 23;26:61-66. doi: 10.1016/j.coph.2015.10.002. [Epub ahead of print].
• Di Benedetto B, Rupprecht R and Czeh B. “Talking to the synapse: how antidepressants can target glial cells to reshape brain circuits”. Curr Drug Targets. 2013 Oct;14(11):1329-35.
• Di Benedetto B and Rupprecht R. “Targeting glia cells: novel perspectives for the treatment of neuropsychiatric diseases”. Current Neuropharmacology. 2013 Mar;11(2):171-85 - Invited contribution.
• Di Benedetto B, Radecke J, Schmidt MV, Rupprecht R. “Acute antidepressant treatment differently modulates ERK/MAPK activation in neurons and astrocytes in the adult mouse prefrontal cortex”. Neuroscience. 2013 Mar 1;232:161-8.
• Czéh B and Di Benedetto B. “Antidepressants act on astrocytes: evidence and functional implications”. Eur Neuropsychopharmacol. 2013 Mar;23(3):171-85.
• Di Benedetto B, Kühn R, Nothdurfter C, Rein T, Wurst W, and Rupprecht R. “N-desalkylquetiapine Activates ERK1/2 to Induce GDNF Release in C6 Glioma Cells: a Putative Cellular Mechanism for Quetiapine as Antidepressant”. Neuropharmacology. 2012 Jan;62(1):209-16 – invited contribution for the Special Issue “Anxiety and depression”.
• Di Benedetto B, Wefers B, Wurst W and Kühn R. “Local Knockdown of ERK2 in the Adult Mouse Brain Via Adeno-Associated Virus-Mediated RNA Interference”. Mol Biotechnol. 2009 Mar;41(3):263-9.
• Di Benedetto B, Kallnik M, Weisenhorn DM, Falls WA, Wurst W and H?lter SM. “Activation of ERK/MAPK in the lateral amygdala of the mouse is required for acquisition of a Fear Potentiated Startle response”. Neuropsychopharmacology. 2009 Jan;34(2):356-66. [Epub 2008 Apr 23].
• Di Benedetto B, Hitz C, H?lter SM, Kühn R, Vogt Weisenhorn DM and Wurst W. “Differential mRNA Distribution of Components of the ERK/MAPK Signalling Cascade in the Adult Mouse Brain”. J Comp Neurol. 2007 Jan 20; 500 (3): 542-556.
• Muzio L, Di Benedetto B, Stoykova A, Boncinelli E, Gruss P, Mallamaci A. “Conversion of cerebral cortex into basal ganglia in Emx2(-/-) Pax6(Sey/Sey) double-mutant mice”. Nat Neurosci. 2002 Aug; 5(8):737-45.
• Muzio L, Di Benedetto B, Stoykova A, Boncinelli E, Gruss P, Mallamaci A. “Emx2 and Pax6 control regionalization of the pre-neuronogenic cortical primordium”. Cereb Cortex. 2002 Feb; 12(2):129-39.